共 50 条
Mantle Cell Lymphoma With Mantle Zone Growth Pattern A Clinicopathologic Study of 35 Cases
被引:0
|作者:
Yuan, Ji
[1
]
Li, Shaoying
[3
]
Liu, Xin
[4
]
Su, Ruijun Jeanna
[5
]
Chen, Mingyi
[6
]
Wu, Xiaojun
[7
]
Zheng, Gang
[7
]
Smith, Lynette M.
[2
]
Wang, Lifu
[3
,8
]
Li, Yanxia
[9
]
Liu, Cynthia
[10
]
Zhou, Jiehao
[11
]
Shen, Qi
[12
]
Zhang, Linsheng
[13
]
Wang, Endi
[4
]
Xu, Mina L.
[14
]
Pan, Zenggang
[14
]
机构:
[1] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[5] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA
[6] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA
[7] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA
[8] Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Henan, Peoples R China
[9] Advocate Christ Med Ctr, Dept Pathol, Oak Lawn, IL USA
[10] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA
[11] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA
[12] Cent Florida Pathol Associates, Orlando, FL USA
[13] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[14] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词:
Mantle cell lymphoma;
Mantle zone growth pattern;
SOX11;
Cyclin D1;
IN-SITU;
HISTOPATHOLOGY;
PROLIFERATION;
DISEASE;
INDEX;
D O I:
10.1093/AJCP/AQZ043
中图分类号:
R36 [病理学];
学科分类号:
100104 ;
摘要:
Objectives: To characterize the clinical and pathologic features of mantle cell lymphoma with mantle zone growth pattern (MCL-MZGP). Methods: The clinicopathologic data from 35 cases of MCL-MZGP obtained in 12 centers were analyzed. Results: The patients with MCL-MZGP typically sought treatment at high clinical stages (81%). Intriguingly, 40% (14/35) of cases were incidentally noted. The lymph nodes with MCL-MZGP showed preserved architecture and expanded mantles containing lymphoma cells with classic or small cell cytology. MCL-MZGP was positive for BCL2 (96%, bright), CD5 (82%, moderate), cyclin D1 (100%), and SOX11 (89%). Clinically, our study revealed no significant difference in the overall survival between patients managed with observation alone and those who received chemotherapy. Conclusions: MCL-MZGP was often incidentally identified and resembled reactive mantles. Therefore, recognition of this unusual morphology emphasizes the utility of cyclin D1 immunostain in the cases with suspicious morphology. However, the clinical significance of these findings is still unclear.
引用
收藏
页码:132 / 145
页数:14
相关论文